Company
Obsidiantx
Unlocking the Promise of Precision Cell Therapy
Also known as Obsidian Therapeutics, Obsidian Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Obsidian Therapeutics, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Obsidian Therapeutics is using its proprietary cytoDRiVE® platform to engineer novel TIL cell therapies.
Funding snapshot
- Total raised
- $32.4MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $32.4M2017-11-29
Funding rounds
- Round, 2017
- $32.4M2017-11-29, SEC form D sold, 8 investors
Products
- Other
- Amsoki-cel (OBX-115)
Loading relationship preview